Latest Foreign Investment News

Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.

The Singapore International Commercial Court has dismissed Poland’s challenge to GreenX Metals’ £183 million Energy Charter Treaty compensation, reinforcing the company’s significant legal victory.

Iron Road has declined to extend Revera Energy’s option to purchase a strategic 24-hectare land parcel at Cape Hardy, marking a significant shift in their green hydrogen project partnership. Two larger land purchase options remain active, with potential buyback rights now triggered.

Toro Energy has secured a crucial Foreign Investment Review Board approval for its acquisition by IsoEnergy, moving the deal closer to completion. Shareholder and court approvals remain as the next steps.

Antilles Gold has received an interim distribution of A$3.25 million from the liquidation of a former subsidiary, directing these funds to support construction of its Nueva Sabana copper-gold mine in Cuba.

RPMGlobal shareholders have decisively approved the proposed acquisition by Caterpillar’s subsidiary, marking a pivotal step toward finalising the deal pending regulatory and court approvals.

Sarytogan Graphite Limited updates investors on its $5 million capital raising, highlighting regulatory approval delays but confirming near-term funding to advance its key graphite project.

RPMGlobal shareholders convened on 19 December 2025 to vote on Caterpillar's $5.00 per share acquisition proposal, with strong board support and regulatory hurdles nearing resolution.

The Australian Competition and Consumer Commission has given the green light to Caterpillar’s proposed acquisition of RPMGlobal, clearing a major regulatory hurdle. The deal now awaits shareholder and Foreign Investment Review Board approvals.

Sierra Nevada Gold (ASX – SNX) has won the rights to explore the expansive As Safra copper-gold project in Saudi Arabia, marking a strategic expansion into a high-potential mining district aligned with the Kingdom’s Vision 2030 ambitions.

The Australian Treasurer has approved Hanwha Corporation’s increase of its direct equity stake in Austal Limited from 9.9% to 19.9%, setting the stage for potential strategic partnerships as Austal rides a wave of record revenues and defence contracts.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.